Surgical and visual outcome following 20-gauge vitrectomy in proliferative diabetic retinopathy over a 10-year period, evidence for change in practice
Authors:
Open Access
- 13 January 2012
- journal article
- research article
- Published by Springer Nature in Eye
- Vol. 26 (4) , 576-582
Abstract
The study reports 10-year anatomical and visual outcome in patients who underwent pars plana vitrectomy (PPV) for complications due to proliferative diabetic retinopathy (PDR). Retrospective analysis of patients undergoing 20G PPV from January 1999 to May 2010 for tractional retinal detachment (TRD) and non-clearing vitreous hemorrhage (NCVH) secondary to PDR recorded prospectively on an electronic patient record. The primary aim was to study anatomical success and eyes with visual acuity (VA) of ≤0.3 logMAR at last follow-up. There were 346 eyes of 249 patients with mean age of 55.63 years and follow-up of 1.44 years. In all, 95.3% of eyes had a flat retina at final follow-up. Overall 136/346 (39.4%) eyes had final VA of logMAR ≤0.3 (Snellen 6/12) and 129 (37.3%) had logMAR ≥1.0 (Snellen 6/60). In all, 50/181 (27.6%) eyes with TRD and 84/165 (50.9%) with NCVH achieved final VA of ≤0.3 logMAR (Snellen 6/12). A total of 218 (63.1%) showed ≥0.3 logMAR improvement from baseline to last follow-up. Both preoperative VA and final postoperative (post-op) VA (PP=0.0002). Silicone oil was used in 5.2% of patients at the primary procedure. In all, 9.2% required removal of non clearing post vitrectomy hemorrhage. Outcomes from vitreoretinal surgery for complications of diabetic retinopathy have improved. In addition, the visual outcome after diabetic vitrectomy steadily improved over the 10-year period, which may in part be due to the move to operate on patients with better vision.Keywords
This publication has 35 references indexed in Scilit:
- Diabetes in Sub Saharan Africa 1999-2011: Epidemiology and public health implications. a systematic reviewBMC Public Health, 2011
- Ischemic Diabetic Retinopathy May Protect against Nuclear Sclerotic CataractAmerican Journal of Ophthalmology, 2010
- Intravitreal bevacizumab (avastin) for proliferative diabetic retinopathy: 6-months follow-upEye, 2007
- Causes of blind certifications in England and Wales: April 1999–March 2000Eye, 2007
- Visual Acuities “Hand Motion” and “Counting Fingers” Can Be Quantified with the Freiburg Visual Acuity TestInvestigative Ophthalmology & Visual Science, 2006
- Visual loss following silicone oil removalBritish Journal of Ophthalmology, 2005
- Visual loss after silicone oil removalBritish Journal of Ophthalmology, 2005
- Visual loss may be due to silicone oil tamponade effect rather than silicone oil removalBritish Journal of Ophthalmology, 2005
- Visual loss following removal of intraocular silicone oilBritish Journal of Ophthalmology, 2005
- Diabetic retinopathy in a black populationOphthalmology, 1999